Q-Line Biotech's shares made a strong debut on the NSE SME platform, opening at ₹452, which is nearly 32% higher than its issue price of ₹343. The stock continued to gain momentum during the trading session, reaching ₹460, representing an increase of over 34% from the issue price. This performance indicates robust investor demand for the company's shares following its initial public offering. The listing on NSE SME provides Q-Line Biotech with enhanced visibility and access to capital markets, supporting its growth prospects in the biotechnology sector. Q-Line Biotech's share price opened at ₹452 on the NSE SME, up nearly 32% from its issue price of ₹343, and rose further to ₹460 during the session, rising more than 34% from its issue price.